GovWire

Guidance: Medicines eligible for Northern Ireland MHRA Authorised Route

Department Of Health

December 9
18:06 2024

class="gem-c-govspeak govuk-govspeak gem-c-govspeak--direction-ltr govuk-!-margin-bottom-0">

This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).

The listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicines authorisation in Great Britain.

This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).

Updates to this page

Published 16 December 2021
Last updated 9 December 2024 +show all updates
  1. Updated to add and remove products from the list. Added: Aprepitant 125mg capsules and Aprepitant 80mg capsules. Removed: Briviact 10mg/ml oral solution - Brivaracetam 50mg/5ml oral solution sugar free.

  2. Updated to add products to the list. Added: Emblaveo 1.5g/0.5g powder for concentrate for solution for infusion vials - Aztreonam 1.5g / Avibactam 500mg powder for solution for infusion vials.

  3. Updated to add items to the list and to correct one item. Added: Zubsolv 1.4mg/0.36mg sublingual tablets - Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free; Zubsolv 2.9mg/0.71mg sublingual tablets - Buprenorphine 2.9mg / Naloxone 710microgram sublingual tablets sugar free; Zubsolv 5.7mg/1.4mg sublingual tablets - Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free; and Zubsolv 8.6mg/2.1mg sublingual tablets - Buprenorphine 8.6mg / Naloxone 2.1mg sublingual tablets sugar free. Corrected: 'Methotrexate 15mg/0.3ml solution for injection pre-filled syringes' to 'Methotrexate 15mg/0.3ml solution for injection pre-filled pens'.

  4. Updated to add and remove products from the list: Added: Vegzelma 100mg/4ml concentrate for solution for infusion vials - Bevacizumab 100mg/4ml solution for infusion vials; and Vegzelma 400mg/16ml concentrate for solution for infusion vial - Bevacizumab 400mg/16ml solution for infusion vials. Removed: Levemir Innolet 100 units/ml solution for injection 3 ml pre filled pens - Insulin Detemir 100 units/ml solution for injection 3ml pre filled disposable devices; and Insulatard Innolet 100 units/ml suspension for injection 3ml pre filled pen - Insulin Isophane human 100 units/ml suspension for injection 3 ml pre filled disposable devices.

  5. Updated to add the following products: Quetiapine 50mg modified-release tablets; Quetiapine 150mg modified-release tablets; Quetiapine 200mg modified-release tablets; Quetiapine 300mg modified-release tablets; Quetiapine 400mg modified-release tablets; and Vinorelbine 10mg/1ml concentrate for solution for infusion vials.

  6. Updated to add and remove products from the list. Added: Methotrexate 15mg/0.3ml solution for injection pre-filled syringes; Neratinib 40mg tablets; Vimpat 150mg tablets - Lacosamide 150mg tablets; Voriconazole 200mg/5ml oral suspension; Lorlatinib 100mg tablets; Vyloy 100mg powder for concentrate for solution for infusion vials - Zolbetuximab 100mg powder for solution for infusion vials; and Entresto 15mg/16mg granules in capsules for opening - Sacubitril 15mg/Valsartan 16mg granules in capsules for opening. Removed: Zonegran 50mg capsules - Zonisamide 50mg capsules.

  7. Updated to add: Methylthioninium chloride (methylene blue) 50mg/10ml solution for injection ampoules.

  8. Updated to add: Ayvakyt 200mg tablets - Avapritinib 200mg tablets.

  9. Updated to add and remove products from the list. Added: Temodal 180mg capsules - Temozolomide 180mg capsules; Lyrica 50mg capsules - Pregabalin 50mg capsules; Lyrica 75mg capsules - Pregabalin 75mg capsules; Lyrica 100mg capsules - Pregabalin 100mg capsules; Dyzantil 200mg modified-release tablets - Sodium valproate 200mg modified-release tablets; Dyzantil 300mg modified-release tablets - Sodium valproate 300mg modified-release tablets; Dyzantil 500mg modified-release tablets - Sodium valproate 500mg modified-release tablets. Removed: Methotrexate 20mg/2ml solution for injection pre-filled syringes; Methotrexate 7.5mg/0.75ml solution for injection pre-filled syringes; Flucloxacillin 1g powder for solution for injection vials.

  10. Updated to add and remove products from the list. Added: Methotrexate 7.5mg/0.75ml solution for injection pre-filled syringes; Methotrexate 20mg/2ml solution for injection pre-filled syringes; Fluorouracil 2.5g/50ml solution for infusion vials; and Elfabrio 5mg/2.5ml concentrate for solution for infusion vials (Pegunigalsidase alfa 5mg/2.5ml solution for infusion vials). Removed: Doxorubicin 2mg/ml concentrate for solution and Temodal 100mg capsules (Temozolomide 100mg capsules).

  11. Added: Flucloxacillin 1g powder for solution for injection vials.

  12. Added: Artesunate 110 mg powder and solvent for solution for injection vials.

  13. Updated to add products to the list. Added Riociguat 2mg tablets; Riociguat 2.5mg tablets; Zanamivir 200mg/20ml solution for infusion vials.

  14. Updated to add: Doxorubicin 2mg/ml concentrate for solution.

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: